Get the latest Science News and Discoveries

UChicago Medicine Comprehensive Cancer Center partners with Lilly to expand clinical trial access - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Related news:

Mounjaro developer Lilly to invest in Korea as AI drug development hub

ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D - EurekAlert!

Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

« Discovery of ‘slow’ electrons in 2D material could lead to new memory device - EurekAlert!

Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics - EurekAlert! »